Results 41 to 50 of about 19,626 (207)
Abstract Background Non‐motor symptoms (NMS), specifically anxiety and depression are major drivers of disability in Parkinson's disease (PD). Prevalence estimates remain inconsistent because of differences in population samples, diagnostic criteria, and symptom overlap, contributing to underdiagnosis and undertreatment.
Marshall Schmidt +4 more
wiley +1 more source
Development and Validation of a New Wearable Mobile Device for the Automated Detection of Resting Tremor in Parkinson's Disease and Essential Tremor. [PDF]
Vescio B +5 more
europepmc +1 more source
Early‐Onset Parkinson's Disease with 22q11.2 Microdeletion and Pathogenic GBA1 Variant
Movement Disorders Clinical Practice, EarlyView.
Nikolai Gil D. Reyes +8 more
wiley +1 more source
A Gap Analysis of Deep Brain Stimulation for Childhood‐Onset Movement Disorders
Abstract Background Deep brain stimulation (DBS) is an established and increasingly utilized therapy for childhood‐onset movement disorders. However, pediatric DBS poses unique challenges that are not adequately addressed by adult‐derived paradigms. Objective To identify key gaps in the current use of DBS in childhood‐onset movement disorders and to ...
Daniela Munoz‐Chesta +6 more
wiley +1 more source
Deep Brain Stimulation after Subthalamic Focused Ultrasound for Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Ayaka Ichise +10 more
wiley +1 more source
Abstract Background Magnetic resonance–guided focused ultrasound (MRgFUS) thalamotomy is effective in treating essential tremor (ET) with an adequate safety profile. Objective The aim of the study was to evaluate the real‐world safety and efficacy of staged bilateral MRgFUS thalamotomy in ET and its impact on patient's quality of life (QoL) and patient‐
Dolores Vilas +8 more
wiley +1 more source
Abstract Objective During the surgical procedure of deep brain stimulation (DBS), insertion of an electrode in the subthalamic nucleus (STN) frequently causes a temporary improvement of motor symptoms, known as the microlesion effect (MLE). The objective of this study was to determine the correlation between the intraoperative MLE and the clinical ...
Stèfan F. Lange +8 more
wiley +1 more source
Apathy in Lewy Body Disorders: A Position Paper
Abstract Apathy is one of the most prevalent and disabling non‐motor symptoms in Parkinson's disease (PD) and dementia with Lewy bodies (DLB), collectively referred to as Lewy body disorders (LBDs). It is associated with reduced quality of life, accelerated cognitive decline, increased caregiver burden, and poorer functional outcomes, yet remains ...
Jaime Kulisevsky +12 more
wiley +1 more source
Abstract Background Studies reporting α‐synuclein seed amplification assay (aSyn‐SAA) results are often cross‐sectional. Objectives In this study, we investigated the intraindividual consistency of aSyn‐SAA results (Amprion) over time from participants in the Parkinson's Precision Medicine Initiative (PPMI).
David G. Coughlin +77 more
wiley +1 more source
GCH1 p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations
Abstract Introduction GCH1 has been implicated in Parkinson's disease (PD), but its risks variants and associations are not well defined. Objectives Our goal was to investigate the clinical relevance and PD risk associated with the GCH1 p.Ser80Asn variant.
Yi Wen Tay +37 more
wiley +1 more source

